IL13 and allergic disease: Here, we show that GJExCR treatment reduced the Th2-mediated immune response in OVA-induced allergy, including dampening of IL-4, IL-5, IL-10, IL-13, TNF-α, INF-γ, chemokine, and IgE expression, in both serum and spleens.